Portfolio 2 Investments
NRG Therapeutics
biotechnology, neuroscience, pharmaceuticals
series-b
€50 M
Sep 2025
Investor
Adaptam Therapeutics
biotech
pre-seed
€3 M
Oct 2025
Lead